We are live on ! Find out more
CM

Crestline Management Portfolio holdings

AUM $53.5M
1-Year Est. Return 80.67%
This Fund
S&P 500
This Quarter Est. Return
+2.53%
1 Year Est. Return
+80.67%
3 Year Est. Return
+80.2%
5 Year Est. Return
+49.87%
10 Year Est. Return
+446.13%
AUM
$842M
AUM Growth
+$160M
Cap. Flow
+$156M
Cap. Flow %
18.53%
Top 10 Hldgs %
32.27%
Holding
254
New
89
Increased
38
Reduced
24
Closed
97

Top Buys

Rank Stock Value
1
TSM icon
TSMC
TSM
+$12.6M
2
WFC icon
Wells Fargo
WFC
+$12.2M
3
HBAN icon
Huntington Bancshares
HBAN
+$11.7M
4
EXC icon
Exelon
EXC
+$11.1M
5
BTU icon
Peabody Energy
BTU
+$10.7M

Top Sells

Rank Stock Value
1
DNLI icon
Denali Therapeutics
DNLI
+$12.4M
2
TFC icon
Truist Financial
TFC
+$8.47M
3
PGR icon
Progressive
PGR
+$8.43M
4
FITB
Fifth Third Bancorp
FITB
+$8.1M
5
CBOE icon
Cboe Global Markets
CBOE
+$6.95M

Sector Composition

Rank Sector Weight
1 Financials 20.66%
2 Technology 20.4%
3 Healthcare 19.9%
4 Utilities 11.57%
5 Industrials 11.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TWCB
151
DELISTED
Bilander Acquisition Corp. Class A Common Stock
TWCB
$229K 0.03%
22,700
-77,300
-77% -$773K
VERA icon
152
Vera Therapeutics
VERA
$2.4B
$228K 0.03%
+29,367
New +$227K
QFTA
153
DELISTED
Quantum FinTech Acquisition Corporation
QFTA
$204K 0.02%
+19,900
New +$202K
PORT
154
DELISTED
Southport Acquisition Corporation
PORT
$186K 0.02%
17,916
-43,721
-71% -$450K
NSTC
155
DELISTED
Northern Star Investment Corp. III
NSTC
$158K 0.02%
+15,663
New +$158K
SAGA
156
DELISTED
Sagaliam Acquisition Corp. Class A Common Stock
SAGA
$106K 0.01%
+10,000
New +$104K
PBYI icon
157
Puma Biotechnology
PBYI
$484M
$98.5K 0.01%
31,884
+3,388
+12% +$12.8K
ADSK icon
158
Autodesk
ADSK
$47.7B
– –
-5,978
Closed -$1.12M
AON icon
159
Aon
AON
$65.7B
– –
-7,385
Closed -$2.22M
APPN icon
160
Appian
APPN
$2.75B
– –
-29,267
Closed -$953K
ASAN icon
161
Asana
ASAN
$2.18B
– –
-23,112
Closed -$318K
BILL icon
162
BILL Holdings
BILL
$4.25B
– –
-7,000
Closed -$763K
BTM
163
DELISTED
Bitcoin Depot
BTM
– –
-14,286
Closed -$1.01M
C icon
164
Citigroup
C
$227B
– –
-88,113
Closed -$3.99M
CABA icon
165
Cabaletta Bio
CABA
$449M
– –
-22,107
Closed -$204K
CBOE icon
166
Cboe Global Markets
CBOE
$28.7B
– –
-55,416
Closed -$6.95M
COHR icon
167
Coherent
COHR
$52.9B
– –
-100,382
Closed -$3.52M
CRBG icon
168
Corebridge Financial
CRBG
$15.6B
– –
-92,082
Closed -$1.85M
CRWD icon
169
CrowdStrike
CRWD
$248B
– –
-56,920
Closed -$1.5M
DD icon
170
DuPont de Nemours
DD
$17B
– –
-44,494
Closed -$3.83M
DIA icon
171
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$45.3B
– –
-18,000
Closed -$5.96M
EWBC icon
172
East-West Bancorp
EWBC
$17.6B
– –
-90,656
Closed -$5.97M
FITB
173
Fifth Third Bancorp
FITB
$49.7B
– –
-246,821
Closed -$8.1M
FLYX icon
174
flyExclusive
FLYX
$115M
– –
-85,000
Closed -$847K
FNV icon
175
Franco-Nevada
FNV
$50.7B
– –
-46,200
Closed -$6.31M
5 6
7
8 9

Similar funds

OM
OV Management Minneapolis, Minnesota $53.5M AUM 5.46% 1-Year Est. Return
ICCON
Investment Counsel Company of Nevada Las Vegas, Nevada $53.5M AUM 26.99% 1-Year Est. Return
HCM
Harspring Capital Management New York $53.7M AUM 23.29% 1-Year Est. Return
ETCM
Evolutionary Tree Capital Management Alexandria, Virginia $53M AUM 24.7% 1-Year Est. Return
IDBONY
Israel Discount Bank of New York New York $54M AUM 13.02% 1-Year Est. Return
PCM
Prentice Capital Management Greenwich, Connecticut $52.9M AUM 2.04% 1-Year Est. Return
TCDRS
Texas County & District Retirement System Austin, Texas $54.6M AUM 22.55% 1-Year Est. Return
FPAM
Feynman Point Asset Management New York $54.7M AUM

Crestline Management's Q1 2023 Portfolio in Review

As of Q1 2023, Crestline Management held 254 positions worth $842M, up 23% from $682M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Crestline Management deployed $156M of net new capital in Q1 2023, opening 89 new positions and adding to 38 existing holdings. Its largest new stake was TSMC: 140,000 shares worth $13M.

By sector, the portfolio is most concentrated in Financials at 21% of assets, down from 23% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Denali Therapeutics, an estimated $12.4M trimmed.

  • Crestline Management's largest Q1 2023 buy was TSMC: 140,000 shares worth $13M.
  • Crestline Management added most to Wells Fargo in Q1 2023, an estimated $12.2M increase.
  • Crestline Management's biggest Q1 2023 reduction was Denali Therapeutics, cutting an estimated $12.4M.
  • Crestline Management fully exited Progressive in Q1 2023, selling an estimated $8.43M.
  • Crestline Management's ten largest holdings make up 32% of its $842M portfolio in Q1 2023.
  • Crestline Management opened 89 new positions and closed 97 in Q1 2023.
  • Crestline Management's portfolio value rose 23% quarter-over-quarter to $842M.

Based on Crestline Management's 13F filing for Q1 2023, filed 15 May 2023.